303 related articles for article (PubMed ID: 32240650)
1. Src-family kinase inhibitors block early steps of caveolin-1-enhanced lung metastasis by melanoma cells.
Ortiz R; Díaz J; Díaz-Valdivia N; Martínez S; Simón L; Contreras P; Lobos-González L; Guerrero S; Leyton L; Quest AFG
Biochem Pharmacol; 2020 Jul; 177():113941. PubMed ID: 32240650
[TBL] [Abstract][Full Text] [Related]
2. Extracellular matrix-specific Caveolin-1 phosphorylation on tyrosine 14 is linked to augmented melanoma metastasis but not tumorigenesis.
Ortiz R; Díaz J; Díaz N; Lobos-Gonzalez L; Cárdenas A; Contreras P; Díaz MI; Otte E; Cooper-White J; Torres V; Leyton L; Quest AF
Oncotarget; 2016 Jun; 7(26):40571-40593. PubMed ID: 27259249
[TBL] [Abstract][Full Text] [Related]
3. CAV1 inhibits metastatic potential in melanomas through suppression of the integrin/Src/FAK signaling pathway.
Trimmer C; Whitaker-Menezes D; Bonuccelli G; Milliman JN; Daumer KM; Aplin AE; Pestell RG; Sotgia F; Lisanti MP; Capozza F
Cancer Res; 2010 Oct; 70(19):7489-99. PubMed ID: 20709760
[TBL] [Abstract][Full Text] [Related]
4. E-cadherin determines Caveolin-1 tumor suppression or metastasis enhancing function in melanoma cells.
Lobos-González L; Aguilar L; Diaz J; Diaz N; Urra H; Torres VA; Silva V; Fitzpatrick C; Lladser A; Hoek KS; Leyton L; Quest AF
Pigment Cell Melanoma Res; 2013 Jul; 26(4):555-70. PubMed ID: 23470013
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-Induced Caveolin-1 Expression Promotes Migration and Invasion of Tumor Cells.
Castillo Bennett J; Silva P; Martinez S; Torres VA; Quest AFG
Curr Mol Med; 2018; 18(4):199-206. PubMed ID: 30259813
[TBL] [Abstract][Full Text] [Related]
6. The interaction between caveolin-1 and Rho-GTPases promotes metastasis by controlling the expression of alpha5-integrin and the activation of Src, Ras and Erk.
Arpaia E; Blaser H; Quintela-Fandino M; Duncan G; Leong HS; Ablack A; Nambiar SC; Lind EF; Silvester J; Fleming CK; Rufini A; Tusche MW; Brüstle A; Ohashi PS; Lewis JD; Mak TW
Oncogene; 2012 Feb; 31(7):884-96. PubMed ID: 21765460
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Src phosphorylation alters metastatic potential of osteosarcoma in vitro but not in vivo.
Hingorani P; Zhang W; Gorlick R; Kolb EA
Clin Cancer Res; 2009 May; 15(10):3416-22. PubMed ID: 19447875
[TBL] [Abstract][Full Text] [Related]
8. Rab5 is required in metastatic cancer cells for Caveolin-1-enhanced Rac1 activation, migration and invasion.
Díaz J; Mendoza P; Ortiz R; Díaz N; Leyton L; Stupack D; Quest AF; Torres VA
J Cell Sci; 2014 Jun; 127(Pt 11):2401-6. PubMed ID: 24659799
[TBL] [Abstract][Full Text] [Related]
9. Caveolin-1 is a risk factor for postsurgery metastasis in preclinical melanoma models.
Lobos-Gonzalez L; Aguilar-Guzmán L; Fernandez JG; Muñoz N; Hossain M; Bieneck S; Silva V; Burzio V; Sviderskaya EV; Bennett DC; Leyton L; Quest AF
Melanoma Res; 2014 Apr; 24(2):108-19. PubMed ID: 24500501
[TBL] [Abstract][Full Text] [Related]
10. Identification of potential biomarkers for measuring inhibition of Src kinase activity in colon cancer cells following treatment with dasatinib.
Serrels A; Macpherson IR; Evans TR; Lee FY; Clark EA; Sansom OJ; Ashton GH; Frame MC; Brunton VG
Mol Cancer Ther; 2006 Dec; 5(12):3014-22. PubMed ID: 17148760
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin E2 Exposure Disrupts E-Cadherin/Caveolin-1-Mediated Tumor Suppression to Favor Caveolin-1-Enhanced Migration, Invasion, and Metastasis in Melanoma Models.
Lobos-González L; Oróstica L; Díaz-Valdivia N; Rojas-Celis V; Campos A; Duran-Jara E; Farfán N; Leyton L; Quest AFG
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069269
[TBL] [Abstract][Full Text] [Related]
12. Genetic ablation of Cav1 differentially affects melanoma tumor growth and metastasis in mice: role of Cav1 in Shh heterotypic signaling and transendothelial migration.
Capozza F; Trimmer C; Castello-Cros R; Katiyar S; Whitaker-Menezes D; Follenzi A; Crosariol M; Llaverias G; Sotgia F; Pestell RG; Lisanti MP
Cancer Res; 2012 May; 72(9):2262-74. PubMed ID: 22396494
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Src family kinases with dasatinib blocks migration and invasion of human melanoma cells.
Buettner R; Mesa T; Vultur A; Lee F; Jove R
Mol Cancer Res; 2008 Nov; 6(11):1766-74. PubMed ID: 19010823
[TBL] [Abstract][Full Text] [Related]
14. Caveolin-1-dependent activation of the metalloprotease TACE/ADAM17 by TGF-β in hepatocytes requires activation of Src and the NADPH oxidase NOX1.
Moreno-Càceres J; Mainez J; Mayoral R; Martín-Sanz P; Egea G; Fabregat I
FEBS J; 2016 Apr; 283(7):1300-10. PubMed ID: 26815118
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of SRC family kinases and receptor tyrosine kinases by dasatinib: possible combinations in solid tumors.
Montero JC; Seoane S; Ocaña A; Pandiella A
Clin Cancer Res; 2011 Sep; 17(17):5546-52. PubMed ID: 21670084
[TBL] [Abstract][Full Text] [Related]
16. Caveolin-1-enhanced motility and focal adhesion turnover require tyrosine-14 but not accumulation to the rear in metastatic cancer cells.
Urra H; Torres VA; Ortiz RJ; Lobos L; Díaz MI; Díaz N; Härtel S; Leyton L; Quest AF
PLoS One; 2012; 7(4):e33085. PubMed ID: 22505999
[TBL] [Abstract][Full Text] [Related]
17. Dasatinib alters the metastatic phenotype of B16-OVA melanoma in vivo.
Fraser CK; Lousberg EL; Guerin LR; Hughes TP; Brown MP; Diener KR; Hayball JD
Cancer Biol Ther; 2010 Oct; 10(7):715-27. PubMed ID: 20676039
[TBL] [Abstract][Full Text] [Related]
18. The non-receptor tyrosine phosphatase type 14 blocks caveolin-1-enhanced cancer cell metastasis.
Díaz-Valdivia NI; Díaz J; Contreras P; Campos A; Rojas-Celis V; Burgos-Ravanal RA; Lobos-González L; Torres VA; Perez VI; Frei B; Leyton L; Quest AFG
Oncogene; 2020 Apr; 39(18):3693-3709. PubMed ID: 32152405
[TBL] [Abstract][Full Text] [Related]
19. Dasatinib inhibits site-specific tyrosine phosphorylation of androgen receptor by Ack1 and Src kinases.
Liu Y; Karaca M; Zhang Z; Gioeli D; Earp HS; Whang YE
Oncogene; 2010 Jun; 29(22):3208-16. PubMed ID: 20383201
[TBL] [Abstract][Full Text] [Related]
20. CUB-domain-containing protein 1 (CDCP1) activates Src to promote melanoma metastasis.
Liu H; Ong SE; Badu-Nkansah K; Schindler J; White FM; Hynes RO
Proc Natl Acad Sci U S A; 2011 Jan; 108(4):1379-84. PubMed ID: 21220330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
